๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Adrenergic receptors in Parkinson's disease

โœ Scribed by Roland Cash; Merle Ruberg; Rita Raisman; Yves Agid

Book ID
118869163
Publisher
Elsevier Science
Year
1984
Tongue
English
Weight
542 KB
Volume
322
Category
Article
ISSN
0006-8993

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Fipamezole (JP-1730) is a potent ฮฑ2 adre
Fipamezole (JP-1730) is a potent ฮฑ2 adrenergic receptor antagonist that reduces levodopa-induced dyskinesia in the MPTP-lesioned primate model of Parkinson's disease
โœ Juha-Matti Savola; Michael Hill; Mia Engstrom; Hannele Merivuori; Siegfried Wurs ๐Ÿ“‚ Article ๐Ÿ“… 2003 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 148 KB

Previous studies in the MPTP-lesioned primate model of Parkinson's disease have demonstrated that alpha(2) adrenergic receptor antagonists such as idazoxan, rauwolscine, and yohimbine can alleviate L-dopa-induced dyskinesia and, in the case of idazoxan, enhance the duration of anti-parkinsonian acti